Kakkis Emil D

Ultragenyx Pharmaceutical Inc · President & CEO

Kakkis Emil D is listed in public filings as director, officer: President & CEO. This Kakkis Emil D insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Ultragenyx Pharmaceutical Inc (RARE). Investors use Kakkis Emil D's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Ultragenyx Pharmaceutical IncRARE$3.3M132.7k sharesGrant / ExerciseApr 16, 2026$3.3M132.7k shares$24.52--
Ultragenyx Pharmaceutical IncRARE--735.7k sharesGrant / ExerciseApr 16, 2026Disclosure amount unavailable76.7k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Ultragenyx Pharmaceutical IncRARE$15M659k sharesSellMar 2, 2026$1.2M54.4k shares$22.80--
Ultragenyx Pharmaceutical IncRARE--712.9k sharesGrant / ExerciseMar 1, 2026Disclosure amount unavailable71.2k shares----
Ultragenyx Pharmaceutical IncRARE$27M641.7k sharesSellMar 3, 2025$3.1M73.4k shares$42.10--
Ultragenyx Pharmaceutical IncRARE$3.4M78.4k sharesGrant / ExerciseMar 1, 2025$3.4M78.4k shares$42.92--
Ultragenyx Pharmaceutical IncRARE--607.9k sharesGrant / ExerciseMar 1, 2025Disclosure amount unavailable43.3k shares----
Ultragenyx Pharmaceutical IncRARE--715.2k sharesGrant / ExerciseMar 1, 2025Disclosure amount unavailable107.3k shares----
Ultragenyx Pharmaceutical IncRARE$92M2.2M sharesSellFeb 28, 2025$1.1M25k shares$42.48--
Ultragenyx Pharmaceutical IncRARE$92M2.2M sharesSellDec 30, 2024$495.2K11.7k shares$42.23--
Ultragenyx Pharmaceutical IncRARE$110M2.2M sharesSellDec 10, 2024$413.6K8.3k shares$50.00--
Ultragenyx Pharmaceutical IncRARE--2.2M sharesGrant / ExerciseDec 9, 2024Disclosure amount unavailable20k shares----
Ultragenyx Pharmaceutical IncRARE$124M2.2M sharesSellSep 3, 2024$1.1M20k shares$55.85--
Ultragenyx Pharmaceutical IncRARE$113M2.2M sharesSellAug 6, 2024$1.0M20k shares$50.17--